Please ensure Javascript is enabled for purposes of website accessibility

Welcome to Regulatory Rapporteur. This site uses cookies. Read our policy.

  • Skip to main content
  • Skip to navigation
Site name
topra-logo

The Organisation for Professionals in Regulatory Affairs
Site name
Mast navigation
  • Become a member
  • Sign in
Search our site
Menu
Close menu
  • Regulatory Rapporteur - March 2026
  • Pharmaceuticals
    • Back to parent navigation item
    • Pharmaceuticals
    • Artificial intelligence
    • ATMP
    • Biologics
    • Chemistry, manufacturing and controls
    • Clinical trials
    • Non-clinical development
    • Oncology
    • Product information
    • Regulatory procedures
  • Veterinary
  • Medical devices
    • Back to parent navigation item
    • Medical devices
    • Combination products
    • In-vitro diagnostics
    • Software
    • Artificial intelligence
  • Industry news
    • Back to parent navigation item
    • Industry news
    • Industry news
      • Back to parent navigation item
      • Industry news
      • Read latest news
      • Video
  • Commentary
    • Back to parent navigation item
    • Commentary
    • Editorials
    • Podcasts
    • Thought leadership
    • Letters to the Editor
  • Collections
    • Back to parent navigation item
    • Collections
    • Interviews
    • Symposium 2025
    • Symposium 2024
    • Symposium 2023
    • Symposium 2022
    • Symposium 2021
    • Regulatory Careers Live
    • CPD supplements
      • Back to parent navigation item
      • CPD supplements
      • 2021/2022
      • 2020
      • 2019
  • JOIN TOPRA
  • topra-logo

    The Organisation for Professionals in Regulatory Affairs
  • Regulatory Rapporteur - March 2026
  • Pharmaceuticals
      • Artificial intelligence
      • ATMP
      • Biologics
      • Chemistry, manufacturing and controls
      • Clinical trials
      • Non-clinical development
      • Oncology
      • Product information
      • Regulatory procedures
    • March front cover HALF
      Regulatory Rapporteur March 2026 – Contents
    • March cover image
      The innovation era: Where biology meets technology
    • Half page-REGRAP-ISSUE 23-1-January 2026
      Regulatory Rapporteur January 2026 – Contents
  • Veterinary
    • Jana Schalansky
      November 2025 – Contents: Veterinary medicines sessions
    • RR-June-2025-half cover _masthead
      June 2025 – Contents
    • June cover image licensed
      Veterinary medicines: Translating regulation into practice
    • RR-Nov-2024-Half-Cover
      November 2024 – Contents: Veterinary medicines sessions
  • Medical devices
      • Combination products
      • In-vitro diagnostics
      • Software
      • Artificial intelligence
    • JamesWillsPhotography-TOPRAAnnualLecture2026-0124
      TOPRA Annual Lecture 2026: The Global Imperative for Responsible AI in Healthcare
    • HTAR - main image
      The EU’s Health Technology Assessment Regulation: Implementation one year on
    • BRIDGE - main image
      Beyond product approval: Bridging the gap between regulatory success and patient access for biosimilars
  • Industry news
      • Industry news
        • Read latest news
        • Video
    • ACT EU image
      ACT EU issues draft guidance on clinical trials during emergencies
    • FDA AEMS image
      FDA launches new consolidated adverse event reporting system
    • FDA_Ultra rare diseases image
      FDA launches framework for accelerating development of individualised therapies for ultra-rare diseases
  • Commentary
      • Editorials
      • Podcasts
      • Thought leadership
      • Letters to the Editor
    • March cover image
      The innovation era: Where biology meets technology
    • Final cover image
      MedTech in transition: Regulation, risk and real-world impact
    • TOPRA RR JCA 800x533px (6.4 ratio) (002)
      RegRapPod − InConversation with Parexel
  • Collections
      • Interviews
      • Symposium 2025
      • Symposium 2024
      • Symposium 2023
      • Symposium 2022
      • Symposium 2021
      • Regulatory Careers Live
      • CPD supplements
        • 2021/2022
        • 2020
        • 2019
    • Banner_new
      Streamline medical device compliance with BSI Compliance NavigatorSponsored by The UK's National Standards Body
    • AdobeStock_59790119
      The Olaratumab experience
    • AdobeStock_207448226
      Qualification of stride velocity endpoint in Duchenne Muscular Dystrophy
  • JOIN TOPRA
  • More from navigation items

All Botanicals articles

  • RR-Oct-2024-Half-Cover
    Contents

    October 2024 – Contents

    October 2024  |  Vol. 21  |  No. 9

  • botanic_compressed
    Journal

    Botanicals and digestive enzymes demonstrate the complexity and diversity of food supplement regulations in the European Union

    2024-09-13T12:14:00Z

     

  • AdobeStock_922131460_small
    Editorial

    The complexities of botanical regulation

    2024-09-12T14:40:00Z

     

  • RR-Sept-half-cover
    Contents

    September 2024 – Contents

    September 2024  |  Vol. 21  |  No. 8

  • What is Regulatory Affairs?
  • TOPRA Membership
  • Regulatory Rapporteur Editorial Board
  • Regulatory Rapporteur Editorial Area
  • Future Focus Topics
  • FAQs
  • Glossary
  • Privacy Policy
  • ISSN 2755-5070 (online)

    ISSN 1742-8955 (print - legacy)

Regulatory Rapporteur

The peer-reviewed journal, published 11 times per year and available free to TOPRA members.

Follow TOPRA
topra-logo

The Organisation for Professionals in Regulatory Affairs

TOPRA office
TOPRA Publishing, Third floor, City Reach, 5 Greenwich View Place, London E14 9NN, UK
Tel: +44 (0) 20 7510 2560
Email: publications@topra.org

TOPRA AISBL
Blvd du Souverain 280, 1160 Brussels, Belgium
Tel: +32 (0) 2 808 72 70

  • Contact us
  • Copyright © 2015-2026 The Organisation for Professionals in Regulatory Affairs Ltd. t/a Regulatory Rapporteur - All rights reserved

Site powered by Webvision Cloud